Cumberland Pharmaceuticals Inc.
Compositions and methods of treating cardiac fibrosis with ifetroban

Last updated:

Abstract:

The present invention is directed to methods of treating, preventing, and/or ameliorating fibrosis syndrome, and in particular cardiac fibrosis, by administration of a therapeutically effective amount of ifetroban, or a pharmaceutically acceptable salt thereof.

Status:
Grant
Type:

Utility

Filling date:

23 Apr 2019

Issue date:

10 Mar 2020